Part 1/6:
The Intersection of Health, Politics, and Big Pharma
In recent discussions surrounding healthcare in America, the meeting between Donald Trump and Robert F. Kennedy Jr. (RFK) has stirred considerable interest. Their conversation, which likely touched on various pressing health issues, highlighted two significant topics: the rising costs of prescription drugs and the role of the pharmaceutical industry as a middleman in healthcare. With both Trump and RFK expressing concerns about the current healthcare system, their dialogue suggests a potential bipartisan approach to tackling the inefficiencies within the system.